The safety and efficacy of two celloid iron supplements in young women with mild anaemia comparing baseline serum ferritin and haemoglobin concentrations with post-treatment levels over a 4-week treatment period.

Blackmores Pty Ltd0 个研究点目标入组 20 人开始时间: 2005年10月13日最近更新: 2020年1月13日

试验速览

暂无简介。

•Good general health. Haemoglobin levels 10-12g/dl. Serum ferritin <20mg/L. Non-smoker.

•Use of iron supplements 4 weeks before recruitment Liver function enzymes >3 times the upper limit of normal at baseline Hemochromatosis Polycythemia Sickle cell anaemia Gastro intestinal disorders Heart disease Taking oral anticoagulants Past allergic responses to iron supplementation Pregnancy or breast feeding Menorrhagia Consumption of more than 14 standard alcoholic drinks per week Conditions that compromise digestion or absorption of iron Taking antibiotics Taking zinc supplements Individuals who have had a gastrectomy Peptic or gastric ulcer Renal disease Affective disorders Subjects unwilling to comply with study protocol Poor venous access Any other condition, which in the opinion of the investigators could compromise the study.

发起方

Blackmores Pty Ltd